• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHB2200120 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2022-09-01 view
JXHB2200121 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2022-09-01 view
JXHL1900234 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Import Drug Application 2019-09-21 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2019-09-20 view
JXHL1900235 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Import Drug Application 2019-09-21 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2019-09-20 view
JYHB2000055 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2020-01-21 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2020-01-20 view
JYHB2000054 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2020-01-21 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2020-01-20 view
JYHB2000201 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2020-03-14 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-05-22 view
JYHB2000202 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2020-03-14 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-05-22 view
JXHB2100007 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2021-01-14 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2021-01-13 view
JXHB2100006 PF-06700841片 brepocitinib Tablet Chemical Drugs(1) Supplementary Application 2021-01-14 辉瑞投资有限公司 Pfizer Investment Co Ltd In Review 2021-01-13 view